Finance

Lists
4502:TYO
Takeda Pharmaceutical Co Ltd
JP¥ ६,९७३.००
+०.३३%
(+२३.००) 1D
नोभेम्बर २०, १५:३०:०० GMT+९  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4502...
Open
JP¥ ६,८५०
High
JP¥ ७,०१६
Low
JP¥ ६,८४६
Mkt. cap
१.१२ शंख
Avg. vol.
४८.१२ लाख
Volume
७६.६६ लाख
Dividend
२.९०%
Quarterly dividend
JP¥ ५१
Ex-dividend date
२०२७ मार्च ३०
P/E ratio
३३३.००
52-wk high
JP¥ ७,०३७
52-wk low
JP¥ ४,३८४
EPS
JP¥ २१
Shares outstanding
७८.४५ करोड
No. of employees
४७ हजार
Open
JP¥ ६,८५०
High
JP¥ ७,०१६
Low
JP¥ ६,८४६
Mkt. cap
१.१२ शंख
Avg. vol.
४८.१२ लाख
Volume
७६.६६ लाख
Dividend
२.९०%
Quarterly dividend
JP¥ ५१
Ex-dividend date
२०२७ मार्च ३०
P/E ratio
३३३.००
52-wk high
JP¥ ७,०३७
52-wk low
JP¥ ४,३८४
EPS
JP¥ २१
Shares outstanding
७८.४५ करोड
No. of employees
४७ हजार
News stories
From web sources and news partners
SAP News Center
SAP News Center
·
३ घण्टा पहिले
Takeda Turns to SAP S/4HANA to Support Digital Transformation
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the largest pharmaceutical company in Japan, third largest such company in Asia behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees४७ हजार
Founded१७८१ जुन १२
Headquarters-
SectorHealth Care
Industry-
Websitetakeda.com
Last report
२०२६ अक्टोबर २९
Fiscal period
Q2 2027
- / -
Revenue / Est. (JPY)
११.८७ खरब / ११.५६ खरब
+२.७१%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
११.९२ खरब
१०.९५ खरब
१२.२० खरब
११.८७ खरब
Cost of goods sold
४.०१ खरब
४.५३ खरब
४.०७ खरब
३.९२ खरब
Cost of revenue
४.०१ खरब
४.५३ खरब
४.०७ खरब
३.९२ खरब
Research and development expenses
१.७५ खरब
१.८८ खरब
१.६७ खरब
१.७१ खरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.८३ खरब
२.९२ खरब
२.८७ खरब
२.७२ खरब
Operating expense
६.६१ खरब
५.२० खरब
६.१३ खरब
५.०४ खरब
Total operating expenses
१०.६२ खरब
९.७३ खरब
१०.१९ खरब
८.९६ खरब
Operating income
१.२९ खरब
१.२२ खरब
२.०१ खरब
२.९१ खरब
Other non operating income
-१.९७ खरब
१.८२ खरब
-३.५४ अरब
-५०.६९ अरब
EBT including unusual items
१.३४ खरब
-४.५५ खरब
१.६३ खरब
१.५६ खरब
EBT excluding unusual items
१.१४ खरब
७१.४९ अरब
१.६२ खरब
२.४२ खरब
Income tax expense
३०.१३ अरब
-८६.६२ अरब
४९.४६ अरब
-३६.४९ अरब
Effective tax rate
२२.५१%
१९.०४%
३०.४०%
-२३.४०%
Other operating expenses
६७.१३ अरब
-६४.२७ अरब
५३.१७ अरब
-२१.५२ अरब
Net income
१.०४ खरब
-३.६८ खरब
१.१३ खरब
१.९२ खरब
Net profit margin
८.७०%
-३३.६६%
९.२८%
१६.२१%
Earnings per share
-
-
-
-
Interest and investment income
१.८१ खरब
-
-
३९.१८ अरब
Interest expense
-
-२.४० खरब
-३५.७० अरब
-३७.३० अरब
Net interest expenses
१.८१ खरब
-२.४० खरब
-३५.७० अरब
१.८८ अरब
Depreciation and amortization charges
-
-
-
-
EBITDA
३.२० खरब
१.९३ खरब
३.६४ खरब
४.५६ खरब
Gain or loss from assets sale
३५.८० करोड
१.४६ अरब
-६.०० अरब
८.८४ अरब
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू